Last €21.49 EUR
Change Today +0.62 / 2.99%
Volume 0.0
ILR On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 6:51 AM 10/21/14 All times are local (Market data is delayed by at least 15 minutes).

impax laboratories inc (ILR) Snapshot

Open
€21.40
Previous Close
€20.87
Day High
€21.49
Day Low
€21.02
52 Week High
07/4/14 - €22.90
52 Week Low
10/22/13 - €14.44
Market Cap
1.5B
Average Volume 10 Days
62.0
EPS TTM
--
Shares Outstanding
70.7M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for IMPAX LABORATORIES INC (ILR)

impax laboratories inc (ILR) Related Businessweek News

No Related Businessweek News Found

impax laboratories inc (ILR) Details

Impax Laboratories, Inc., a specialty pharmaceutical company, develops, manufactures, and markets bioequivalent pharmaceutical products; and develops and markets branded products. The company operates through two segments, Global Pharmaceuticals Division and Impax Pharmaceutical Division. The Global Pharmaceuticals Division develops, manufactures, sells, and distributes generic pharmaceutical products through its global products sales channel for sales of generic prescription products directly to wholesalers, retail drug chains, and others; private label product sales channel for generic over-the-counter (OTC) and prescription products to unrelated third-party customers; Rx partner sales channel for generic prescription products through unrelated third-party pharmaceutical entities; and OTC partner sales channel for OTC products through unrelated third-party pharmaceutical entities, as well as offers research and development services. The Impax Pharmaceutical Division develops proprietary brand pharmaceutical products for the treatment of central nervous system disorders, including migraine, multiple sclerosis, Parkinson’s disease, and postherpetic neuralgia, as well as promotes third-party branded pharmaceutical products through its specialty sales force. The company markets and sells its products to drug wholesalers, warehousing chain drug stores, mass merchandisers, and mail-order pharmacies in the continental United States and the Commonwealth of Puerto Rico. Impax Laboratories, Inc. has a strategic alliance agreement with Teva Pharmaceuticals Curacao N.V to develop and manufacture controlled release generic pharmaceutical products. The company was founded in 1993 and is headquartered in Hayward, California.

973 Employees
Last Reported Date: 02/25/14
Founded in 1993

impax laboratories inc (ILR) Top Compensated Officers

Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $385.0K
President of Impax Pharmaceuticals Division
Total Annual Compensation: $500.5K
President of Global Pharmaceuticals Division
Total Annual Compensation: $486.3K
Senior Vice President, General Counsel and Se...
Total Annual Compensation: $470.2K
Compensation as of Fiscal Year 2013.

impax laboratories inc (ILR) Key Developments

Amedra Pharmaceuticals LLC, CorePharma, L.L.C., Impax Laboratories Inc., Lineage Therapeutics Inc., Tower Holdings, Inc. - M&A Call

To discuss the acquisition transaction between company and Tower Holdings, Inc., including operating subsidiaries CorePharma LLC and Amedra Pharmaceuticals LLC, and Lineage Therapeutics Inc

Impax Eyes Acquisitions

Impax Laboratories Inc. (NasdaqGS:IPXL) is looking for acquisition opportunities. Impax Laboratories has announced the execution of a definitive agreement under which Impax will acquire Tower Holdings. "This transaction is an important step forward in executing our plan to drive growth and create value through strategic acquisitions that enhance our existing strategies," said Fred Wilkinson, President and Chief Executive Officer of Impax.

Brower Piven Announces Class Action Lawsuit Against Impax Laboratories Inc

Brower Piven announced that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Impax Laboratories Inc. securities during the period between May 20, 2013 and July 28, 2014, inclusive.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ILR:GR €21.49 EUR +0.62

ILR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ILR.
View Industry Companies
 

Industry Analysis

ILR

Industry Average

Valuation ILR Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMPAX LABORATORIES INC, please visit www.impaxlabs.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.